THUNDER BAY — Novo Nordisk Canada has issued a voluntary recall of its semiglutide injections, Ozempic, due to potential cracked glass in the cartridges.
The recall lot number is RZFFE55.
A spokesperson from Rexall Pharmacy confirmed the recalled cartridges are the 1mg dose in a blue box but said their pharmacy on Arthur Street did not receive any of the recalled batch.
The recall is characterized as a Type II, which does not require call-outs to patients.
According to Health Canada, a Type II recall is “a situation in which the use of, or exposure to, a product may cause temporary adverse health consequences or where the probability of serious adverse health consequences is remote.”
It is recommended by Health Canada to take these steps if you believe you have a recalled cartridge.
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
